Latest Risk factors of breast cancer Stories
Many risk factors for breast cancer are well studied and documented.
According to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), exposure to electrical light between dusk and bedtime strongly suppresses melatonin levels and may impact physiologic processes regulated by melatonin signaling, such as sleepiness, thermoregulation, blood pressure and glucose homeostasis.
Body fat distribution does not play an important role in the incidence of every subtype of premenopausal breast cancer, but is associated with an increased risk for estrogen receptor (ER)â€“negative breast cancer.
Results from an ongoing study examining two drugs to prevent breast cancer found that the drug raloxifene (Evista) was as almost effective as the standard drug tamoxifen (Nolvadex) and also produced fewer side effects.
Hormone Replacement Therapy (HRT) utilizing estrogen alone (the exogenous estrogen) provides a protective effect in reducing breast cancer risk, according to a new study.
While endogenous estrogen (i.e., estrogen produced by ovaries and by other tissues) does have a well-known carcinogenic impact, hormone replacement therapy (HRT) utilizing estrogen alone (the exogenous estrogen) provides a protective effect in reducing breast cancer risk.
Every year in the United States about 40% of women with breast cancer undergo a mastectomy.
EMERYVILLE, Calif., Dec. 8, 2010 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI) today announced the publication of a study demonstrating that ERb causes cancer cell growth arrest by inactivating critical genes and enzymes responsible for cell growth.
Age at First Pregnancy Associated with Breast Cancer Risk Having children later in life or not at all, combined with a trend in obesity may increase risk of a breast cancer that is hard to detect. Madison, WI (Vocus) December 1, 2010 Having children later in life or not at all, combined with a trend in obesity may increase risk of a breast cancer that is hard to detect. A UW School of Medicine and Public Health research team led by scientists Polly Newcomb and Amy Trentham-Dietz conducted a...
In a new UCSF study of more than 2 million mammogram screenings performed on nearly 700,000 women in the United States, scientists for the first time show a direct link between reduced hormone therapy and declines in ductal carcinoma in situ (DCIS) as well as invasive breast cancer.